Literature DB >> 20096014

Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Lily J Huang1, Yu-Min Shen, Gamze B Bulut.   

Abstract

Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096014      PMCID: PMC2864346          DOI: 10.1111/j.1365-2141.2009.08069.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  101 in total

1.  Absence of mutations of the EPO-receptor gene in Greek patients with familial polycythemia.

Authors:  Lambros K Bourantas; Anthoula Chatzikyriakidou; Aggeliki Dasoula; Marika Syrrou; Konstantinos L Bournatas; Ioannis Georgiou
Journal:  Eur J Haematol       Date:  2006-04-11       Impact factor: 2.997

Review 2.  Myeloproliferative disorders.

Authors:  Ross L Levine; D Gary Gilliland
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

3.  Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization.

Authors:  I Levin; J Cohen; L Supino-Rosin; A Yoshimura; S S Watowich; D Neumann
Journal:  FEBS Lett       Date:  1998-05-08       Impact factor: 4.124

4.  [Familial diphosphoglycerate mutase deficiency: hematological and biochemical study].

Authors:  P Cartier; D Labie; J P Leroux; A Najman; F Demaugre
Journal:  Nouv Rev Fr Hematol       Date:  1972 May-Jun

5.  Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.

Authors:  S S Watowich; X Xie; U Klingmuller; J Kere; M Lindlof; S Berglund; A de la Chapelle
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

6.  Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.

Authors:  P A Tilbrook; G A Palmer; T Bittorf; D J McCarthy; M J Wright; M K Sarna; D Linnekin; V S Cull; J H Williams; E Ingley; J Schneider-Mergener; G Krystal; S P Klinken
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.

Authors:  Elisa Fermo; Paola Bianchi; Cristina Vercellati; Anna Paola Marcello; Massimo Garatti; Ornella Marangoni; Wilma Barcellini; Alberto Zanella
Journal:  Blood Cells Mol Dis       Date:  2008-03-17       Impact factor: 3.039

8.  Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.

Authors:  E Rumi; F Passamonti; L Pagano; M Ammirabile; L Arcaini; C Elena; A Flagiello; R Tedesco; C Vercellati; A P Marcello; D Pietra; R Moratti; M Cazzola; M Lazzarino
Journal:  J Intern Med       Date:  2008-09-10       Impact factor: 8.989

9.  Familial and congenital polycythemias: a diagnostic approach.

Authors:  Tom Van Maerken; Kathleen Hunninck; Luc Callewaert; Yves Benoit; Geneviève Laureys; Joris Verlooy
Journal:  J Pediatr Hematol Oncol       Date:  2004-07       Impact factor: 1.289

10.  Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.

Authors:  Rita Sulahian; Ondine Cleaver; Lily Jun-shen Huang
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

View more
  14 in total

1.  A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.

Authors:  Naohisa Toriumi; Makoto Kaneda; Naoki Hatakeyama; Hiromi Manabe; Kazuki Okajima; Yukari Sakurai; Masayo Yamamoto; Takeo Sarashina; Katsuya Ikuta; Hiroshi Azuma
Journal:  Int J Hematol       Date:  2018-04-05       Impact factor: 2.490

2.  Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.

Authors:  Gamze B Bulut; Rita Sulahian; Huiyu Yao; Lily Jun-shen Huang
Journal:  Blood       Date:  2013-10-10       Impact factor: 22.113

3.  Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Authors:  Nathalie Cervera; Anne-Catherine Lhoumeau; José Adélaïde; Arnaud Guille; Anne Murati; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum; Véronique Gelsi-Boyer
Journal:  Haematologica       Date:  2019-10-10       Impact factor: 9.941

4.  Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Yongjin Li; Kathryn G Roberts; Stephanie M Dobson; Jaeseung C Kim; Debbie Payne-Turner; Richard C Harvey; Marcus Valentine; Kelly McCastlain; John Easton; Donald Yergeau; Laura J Janke; Ying Shao; I-Ming L Chen; Michael Rusch; Sasan Zandi; Steven M Kornblau; Marina Konopleva; Elias Jabbour; Elisabeth M Paietta; Jacob M Rowe; Ching-Hon Pui; Julie Gastier-Foster; Zhaohui Gu; Shalini Reshmi; Mignon L Loh; Janis Racevskis; Martin S Tallman; Peter H Wiernik; Mark R Litzow; Cheryl L Willman; John D McPherson; James R Downing; Jinghui Zhang; John E Dick; Stephen P Hunger; Charles G Mullighan
Journal:  Cancer Cell       Date:  2016-02-08       Impact factor: 31.743

5.  A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia.

Authors:  Kacey O'Rourke; David J Fairbairn; Kathryn A Jackson; Kirk L Morris; Siok-Keen Tey; Glen A Kennedy
Journal:  Int J Hematol       Date:  2011-03-25       Impact factor: 2.490

6.  EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Authors:  Silverio Perrotta; Valeria Cucciolla; Marcella Ferraro; Luisa Ronzoni; Annunziata Tramontano; Francesca Rossi; Anna Chiara Scudieri; Adriana Borriello; Domenico Roberti; Bruno Nobili; Maria Domenica Cappellini; Adriana Oliva; Giovanni Amendola; Anna Rita Migliaccio; Patrizia Mancuso; Ines Martin-Padura; Francesco Bertolini; Donghoon Yoon; Josef T Prchal; Fulvio Della Ragione
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

7.  Identification of the transcription factor MAZ as a regulator of erythropoiesis.

Authors:  Darya Deen; Falk Butter; Deborah E Daniels; Ivan Ferrer-Vicens; Daniel C J Ferguson; Michelle L Holland; Vasiliki Samara; Jacqueline A Sloane-Stanley; Helena Ayyub; Matthias Mann; Jan Frayne; David Garrick; Douglas Vernimmen
Journal:  Blood Adv       Date:  2021-08-10

Review 8.  Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.

Authors:  Douglas Tremblay; Abdulraheem Yacoub; Ronald Hoffman
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-26       Impact factor: 3.722

9.  Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.

Authors:  Seema Singh; Rakesh Verma; Anamika Pradeep; Karen Leu; R Bruce Mortensen; Peter R Young; Miho Oyasu; Peter J Schatz; Jennifer M Green; Don M Wojchowski
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

10.  The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.

Authors:  Ming-Chang Hu; Mingjun Shi; Han J Cho; Jianning Zhang; Alevtina Pavlenco; Shuzhen Liu; Sachdev Sidhu; Lily J-S Huang; Orson W Moe
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.